Lv61
2280 积分 2022-08-19 加入
An Intercompany Perspective on Compatibility and In-use Stability Studies to Enable Administration Of Biopharmaceutical Drug Products
1个月前
已完结
Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products
1个月前
已完结
Colloidal Stability Assessment of a Model Antibody Oligonucleotide Conjugate
1个月前
已完结
Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice
1个月前
已完结
Quantitative Laser Diffraction Mediated Detection of Submicron and Subvisible Aggregates (100 nm–10 μm) in Biotherapeutics: Need for Regulatory Attention To this Neglected Particle Size Range
1个月前
已完结
Modeling Filtration Flow Rate in Peristaltic Pump Systems for High-Viscosity Bovine Serum Albumin: A Multivariate Nonlinear Approach
1个月前
已完结
Engineering the subcutaneous delivery of antibody-drug conjugates
1个月前
已完结
Reaching new heights? Maximum subcutaneous injection volumes from a technical and clinical development strategy perspective
1个月前
已完结
Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish
1个月前
已完结
Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish
2个月前
已完结
皖公网安备34019202002308
